Key result
Systemic tPA fails to prevent fatal cardiac arrest from complete RV thrombus in Ebstein anomaly.
Why the study?
The risk and management of right ventricular thrombus formation in pediatric patients with Ebstein anomaly and Glenn physiology are not well characterized due to its rarity.
Case Report (n=1)
No
Complete right ventricular thrombus is a rare, life-threatening complication in pediatric Ebstein anomaly with Glenn physiology, emphasizing the challenges of medical management and anticoagulation in this complex population.
Answers are grounded in this paper and cite their sources.
May warrant heightened thrombosis vigilance in pediatric Ebstein-Glenn patients; leaves open optimal anticoagulation strategies.
Ebstein anomaly is a rare cardiac anomaly accounting for 0.3% to 0.5% of congenital heart defects. The anatomic defect resulting in Ebstein anomaly involves inferior displacement of the tricuspid valve into the right ventricle, resulting in tricuspid regurgitation, atrialization of the right ventricle, and right ventricular (RV) hypoplasia. Disease severity can vary significantly, with severe forms requiring surgical intervention.1
No takes yet. Share an insight, caveat, or question.
Shah et al. (2026) conducted a case report in Ebstein anomaly with right ventricular thrombus (n=1). Systemic tissue plasminogen activator (tPA) was evaluated on Clinical outcome. A 4-year-old boy with Ebstein anomaly and Glenn physiology developed a complete right ventricular thrombus and experienced fatal cardiac arrest despite treatment with systemic tPA.
Synapse has enriched 10 related papers. Consider them for comparative context: